1. Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis
    Swathikan Chidambaram et al, 2022, Diseases of the Esophagus CrossRef
  2. The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions
    Audrey E. Kam et al, 2021, Annals of Surgical Oncology CrossRef
  3. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
    Natasha Honoré et al, 2021, Cancers CrossRef
  4. Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study
    Tae Hoon Lee et al, 2024, Cancer Research and Treatment CrossRef
  5. Approach to Localized Squamous Cell Cancer of the Esophagus
    Chloe Weidenbaum et al, 2022, Current Treatment Options in Oncology CrossRef
  6. Biomarker Testing and Role of Tyrosine Kinase Inhibitors and Immunotherapy for Esophageal Squamous Cell Carcinoma
    Muftah Mahmud et al, 2024, Foregut: The Journal of the American Foregut Society CrossRef
  7. Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma
    Xin Wang et al, 2022, Clinical and Translational Medicine CrossRef
  8. Bioinformatics Characterization of Candidate Genes Associated with Gene Network and miRNA Regulation in Esophageal Squamous Cell Carcinoma Patients
    Bharathi Muruganantham et al, 2022, Applied Sciences CrossRef
  9. A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy
    Liyan Xue et al, 2022, British Journal of Cancer CrossRef
  10. Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non–small-cell lung cancer: a propensity-matched retrospective study
    Xia Wang et al, 2021, BMC Cancer CrossRef
  11. Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
    Lianshuang Xia et al, 2023, Radiation Oncology CrossRef
  12. Application and Prospect of Detection Methods of Circulating Tumor Cells in Esophageal Cancer
    叶星 张, 2023, Advances in Clinical Medicine CrossRef
  13. An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis
    Yaozhong Zhang et al, 2024, BMC Cancer CrossRef